Xylem: Citigroup cuts target price to $148 from $172
XYL•Citigroup cut its target price for Xylem to $148 from $172.
Related News
Rhythm Pharmaceuticals target price raised to $130 from $105
RYTM•
Whirlpool Corporation: Citigroup cuts target price to $32 from $48
WHR•
Vera Therapeutics receives market perform rating with $34 target
VERA•
Helmerich & Payne price objective raised to $46 from $44
HP•
Citigroup raises Allison Transmission Holdings to buy from neutral
ALSN•